Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units

INTRODUCTION: At the time of the worrying emergence and spread of bacterial resistance, reducing the selection pressure by reducing the exposure to antibiotics in patients with community-acquired pneumonia (CAP) is a public health issue. In this context, the combined use of molecular tests and bioma...

Descripción completa

Detalles Bibliográficos
Autores principales: Voiriot, Guillaume, Fartoukh, Muriel, Durand-Zaleski, Isabelle, Berard, Laurence, Rousseau, Alexandra, Armand-Lefevre, Laurence, Verdet, Charlotte, Argaud, Laurent, Klouche, Kada, Megarbane, Bruno, Patrier, Juliette, Richard, Jean-Christophe, Reignier, Jean, Schwebel, Carole, Souweine, Bertrand, Tandjaoui-Lambiotte, Yacine, Simon, Tabassome, Timsit, Jean-François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Intensive Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375718/
https://www.ncbi.nlm.nih.gov/pubmed/34408046
http://dx.doi.org/10.1136/bmjopen-2020-048187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375718/
https://www.ncbi.nlm.nih.gov/pubmed/34408046
http://dx.doi.org/10.1136/bmjopen-2020-048187

Ejemplares similares